Pages that link to "Q33561203"
Jump to navigation
Jump to search
The following pages link to Impact of venous thromboembolism and anticoagulation on cancer and cancer survival (Q33561203):
Displaying 50 items.
- Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review (Q26753853) (← links)
- Heparin in malignant glioma: review of preclinical studies and clinical results (Q26821781) (← links)
- Anticoagulants in cancer (Q26825228) (← links)
- The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials (Q26852293) (← links)
- Venous thromboembolism in the cancer population: pathology, risk, and prevention (Q26996508) (← links)
- M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis (Q28743550) (← links)
- Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data. (Q31104892) (← links)
- Treating venous thromboembolism in patients with cancer (Q33400564) (← links)
- Risk of thrombosis in cancer and the role of supportive care (transfusion, catheters, and growth factors). (Q33431426) (← links)
- Venous thromboembolism prophylaxis and treatment in cancer: a consensus statement of major guidelines panels and call to action (Q33561213) (← links)
- Evidence-based guidance on venous thromboembolism in patients with solid tumours (Q33763946) (← links)
- Venous thromboembolism and prognosis in cancer. (Q33886515) (← links)
- Guidelines for treatment and prevention of venous thromboembolism among patients with cancer (Q35174604) (← links)
- Clinical Use of the Low-Molecular-Weight Heparins in Cancer Patients: Focus on the Improved Patient Outcomes (Q35368813) (← links)
- High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension (Q35529221) (← links)
- Clinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection (Q35808697) (← links)
- Low local blood perfusion, high white blood cell and high platelet count are associated with primary tumor growth and lung metastasis in a 4T1 mouse breast cancer metastasis model. (Q35856677) (← links)
- Clinical and Prognostic Significance of Preoperative Plasma Fibrinogen Levels in Patients with Operable Breast Cancer (Q35901137) (← links)
- The comparison of plasma D-dimer levels in benign and malignant tumors of cervix, ovary and uterus (Q35929997) (← links)
- D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy (Q36009299) (← links)
- Cancer Cell-Derived Extracellular Vesicles Are Associated with Coagulopathy Causing Ischemic Stroke via Tissue Factor-Independent Way: The OASIS-CANCER Study (Q36079937) (← links)
- High D-dimer levels are associated with poor prognosis in cancer patients (Q36133005) (← links)
- Effect of Fraxiparine, a type of low molecular weight heparin, on the invasion and metastasis of lung adenocarcinoma A549 cells (Q36216588) (← links)
- Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism (Q36295906) (← links)
- Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis (Q36843779) (← links)
- The antineoplastic effect of low-molecular-weight heparins - a literature review (Q36936771) (← links)
- Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study (Q37060686) (← links)
- Venous thromboembolism in the patient with cancer: focus on burden of disease and benefits of thromboprophylaxis (Q37190522) (← links)
- Characteristics of Venous Thromboembolism in Pancreatic Adenocarcinoma in East Asian Ethnics: A Large Population-Based Observational Study. (Q37206411) (← links)
- Impact of cardiovascular comorbidity on ovarian cancer mortality (Q37315173) (← links)
- Cancer, clots and consensus: new understanding of an old problem. (Q37393386) (← links)
- Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study (Q37640879) (← links)
- Heparin as an inhibitor of cancer progression. (Q37784315) (← links)
- Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agents (Q37794614) (← links)
- Thrombophilic state in cancer, Part I: Biology, incidence, and risk factors (Q37863640) (← links)
- Management of venous thromboembolism in patients with cancer (Q37903957) (← links)
- Crosstalk between cancer and haemostasis. Implications for cancer biology and cancer-associated thrombosis with focus on tissue factor (Q37906322) (← links)
- The thrombophilic state in cancer part II: cancer outcomes, occult malignancy, and cancer suppression (Q38001256) (← links)
- Comparing clinicians' use of an anticoagulation management service and usual care in ambulatory oncology. (Q38061872) (← links)
- Coagulation and cancer: biological and clinical aspects (Q38070918) (← links)
- Anticoagulation for prevention and treatment of cancer-related venous thromboembolism. (Q38096441) (← links)
- Improving clinician performance of inpatient venous thromboembolism risk assessment and prophylaxis. (Q38107349) (← links)
- Oral anticoagulants in the management of venous thromboembolism (Q38108205) (← links)
- Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond (Q38129719) (← links)
- Thrombosis in pediatric cancer: identifying the risk factors to improve care (Q38152512) (← links)
- New strategies of VTE prevention in cancer patients (Q38214956) (← links)
- Recent advances in anticoagulant drug delivery (Q38649939) (← links)
- Pre-metastatic niches: organ-specific homes for metastases. (Q38743711) (← links)
- Tissue factor expression determines tumour cell coagulation kinetics (Q39393951) (← links)
- Ascidian dermatan sulfates attenuate metastasis, inflammation and thrombosis by inhibition of P-selectin. (Q39524033) (← links)